Xavier Kurz
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
An extension of the Benefit Risk Assessment of VaccinEs toolkit to evaluate Comirnaty and Spikevax vaccination in the European Union.
Journal: European journal of public health
Published: August 19, 2025
Strengthening Pharmacoepidemiology in a Changing Research Environment: The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP).
Journal: Pharmacoepidemiology and drug safety
Published: July 29, 2025
Lessons Learned on Observed-to-Expected Analysis Using Spontaneous Reports During Mass Vaccination.
Journal: Drug safety
Published: March 07, 2024
Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Lessons Learnt From the MINERVA Project in Europe.
Journal: Pharmacoepidemiology and drug safety
Published: December 22, 2023
Risk of Arterial and Venous Thrombotic Events Among Patients with COVID-19: A Multi-National Collaboration of Regulatory Agencies from Canada, Europe, and United States.
Journal: Clinical epidemiology
Published: November 09, 2023
Utilising the Benefit Risk Assessment of Vaccines (BRAVE) toolkit to evaluate the benefits and risks of Vaxzevria in the EU: a population-based study.
Journal: The Lancet. Digital health
Published: June 23, 2023
Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Development and Pilot of a Metadata List and Catalogue in Europe.
Journal: Pharmacoepidemiology and drug safety
Published: June 16, 2023
A collaborative study of the impact of N-nitrosamines presence and ARB recall on ARB utilization - results from IQVIA™ Disease Analyzer Germany.
Journal: European journal of clinical pharmacology
Published: November 21, 2022
Assessing heterogeneity of electronic health-care databases: A case study of background incidence rates of venous thromboembolism.
Journal: Pharmacoepidemiology and drug safety
Published: September 09, 2022
Contribution of Real-World Evidence in European Medicines Agency's Regulatory Decision Making.
Journal: Clinical pharmacology and therapeutics
Published: August 17, 2022
Artificial intelligence in pharmacovigilance: A regulatory perspective on explainability.
Journal: Pharmacoepidemiology and drug safety
Published: July 27, 2022
HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: June 28, 2022
Last Updated: 09/26/2026